GeneralTop StoryTop StoryLatest News
Deepinder Goyal Responds to Doctors Criticizing Temple Wearable
Sentiment: NeutralHigh Priority
What Happened?
Deepinder Goyal, co-founder of Zomato, defends his brain-monitoring wearable, Temple, against criticism from Indian doctors, revealing a $30 million investment.
Key points
- Deepinder Goyal invested nearly $30 million in Temple, with $20 million from his own funds.
- Temple claims to monitor cerebral blood flow, but lacks peer-reviewed research backing.
- Goyal argues that if Temple were a scam, it would fail quickly due to a 14-day return policy.
- He emphasizes that scientific validation is in progress, with preprints to be released soon.
- Doctors have raised concerns about the device's ability to accurately measure brain blood flow.
Key insights
- Goyal's substantial investment indicates a strong belief in Temple's potential.
- The lack of peer-reviewed studies may hinder consumer acceptance and trust.
- Ongoing scientific validation efforts could enhance the credibility of Temple in the long run.
Why it matters
The debate over Temple's validity could impact consumer trust in health-tech wearables.
Tags
Entities
Deepinder Goyal· PersonZomato· CompanyTemple· ProductIndia· Country
Source
Times Now
